<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00205946</url>
  </required_header>
  <id_info>
    <org_study_id>2004-P-002234-1</org_study_id>
    <secondary_id>2004-P002234-1</secondary_id>
    <nct_id>NCT00205946</nct_id>
  </id_info>
  <brief_title>The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity</brief_title>
  <official_title>The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Affective Neuroscience Laboratory</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Affective Neuroscience Laboratory</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the effects of a single-dose of Wellbutrin XL&#xD;
      (bupropion hydrochloride) on reward processing.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cardinal feature of Major Depressive Disorder is anhedonia, which is a lack of pleasure in&#xD;
      normally enjoyable activities. In order to understand reward processing in depressed&#xD;
      individuals it is also necessary to study reward processing in people who are not depressed.&#xD;
      Bupropion, the active drug in the anti-depressant Wellbutrin XL, has been shown to increase&#xD;
      brain reward functioning in animals. The goal of the present study is to investigate the&#xD;
      effects of Wellbutrin XL administered to psychiatrically healthy individuals as they perform&#xD;
      a computer task known to assess reward processing.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date type="Actual">July 2007</completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Whether an acute dose of bupropion vs. placebo differentially affects the neurobiology and behavior of reward processing in depressed participants.</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupropion</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupropion</intervention_name>
    <description>150 mg of bupropion administered 5 hours before fMRI scanning</description>
    <arm_group_label>Bupropion</arm_group_label>
    <other_name>Wellbutrin XL</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administered 5 hours prior to fMRI scanning (randomly assigned, double blind)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Absence of medical, neurological, and psychiatric illness (including alcohol and&#xD;
             substance abuse)&#xD;
&#xD;
          -  Non-Smoker&#xD;
&#xD;
          -  Right-handed (Chapman and Chapman 1987)&#xD;
&#xD;
          -  Ability to provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Predisposition to seizure (e.g. family history of a seizure disorder, history of head&#xD;
             trauma) or current use of medications that lower the seizure threshold&#xD;
&#xD;
          -  History or current diagnosis of anorexia or bulimia&#xD;
&#xD;
          -  Alcohol or substance abuse within the past year&#xD;
&#xD;
          -  Current usage of Wellbutrin or Zyban or other drugs that contain bupropion&#xD;
&#xD;
          -  Recent discontinuation of alcohol or sedatives (including benzodiazepines)&#xD;
&#xD;
          -  Use of (in the last 2 weeks) medications that may have antidepressant properties (ex.&#xD;
             some herbal supplements)&#xD;
&#xD;
          -  Known allergies to bupropion&#xD;
&#xD;
          -  Currently lactating, pregnant or believe you are likely to be pregnant (enrolled&#xD;
             subjects who are not using reliable contraception and have engaged in sexual&#xD;
             intercourse since their last menstrual period will be given a self-administered&#xD;
             pregnancy test.)&#xD;
&#xD;
          -  Left-handed/ambidextrous&#xD;
&#xD;
          -  Evidence of neurological illness&#xD;
&#xD;
          -  Serious suicide or homicide risk&#xD;
&#xD;
        Concomitant medications other than those listed in the exclusion criteria will be&#xD;
        considered on an individual basis. Oral contraceptives will be allowed.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diego A Pizzagalli, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Depression Clinical and Research Program, Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Affective Neuroscience Laboratory, Department of Psychology, Harvard University</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <study_first_submitted>September 13, 2005</study_first_submitted>
  <study_first_submitted_qc>September 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 21, 2005</study_first_posted>
  <last_update_submitted>December 4, 2007</last_update_submitted>
  <last_update_submitted_qc>December 4, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2007</last_update_posted>
  <responsible_party>
    <name_title>Diego Pizzagalli, Principal Investigator</name_title>
    <organization>Harvard University</organization>
  </responsible_party>
  <keyword>Reward Processing</keyword>
  <keyword>Wellbutrin</keyword>
  <keyword>Bupropion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupropion</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

